Parameter | Total | No growth, n (%), 18 (18) | Fungal growth, n (%), 82 (82) | Significance (p value) | |
---|---|---|---|---|---|
Exacerbation grade, n (%) | Mild | 37 | 7 (18.9) | 30 (81.1) | R |
Moderate | 53 | 10 (18.9) | 43 (81.1) | 0.995a | |
Severe | 10 | 1 (10) | 9 (90) | 0.667a | |
COPD groups, n (%) | A | 13 | 4 (30.8) | 9 (69.2) | R |
B | 16 | 3 (18.8) | 13 (81.2) | 0.667a | |
C | 8 | 0 (0) | 8 (100) | 0.131a | |
D | 63 | 11 (17.5) | 52 (82.5) | 0.273a | |
GOLD (severity of airway limitation), n (%) | 1 | 12 | 3 (25) | 9 (75) | R |
2 | 41 | 2 (4.9) | 39 (95.1) | 0.07a | |
3 | 25 | 6 (24) | 19 (76) | 1a | |
4 | 20 | 6 (30) | 14 (70) | 1a | |
X-ray, n (%) | Normal | 40 | 7 (17.5) | 33 (82.5) | 1b |
Abnormal(hyperinflation and consolidation) | 60 | 11 (18.3) | 49 (81.7) | Â | |
Comorbid diseases, n (%) | Present | 67 | 10 (14.9) | 57 (85.1) | .254a |
Absent | 33 | 8 (24.2) | 25 (75.8) | Â |